Literature DB >> 22903246

Obesity in bipolar disorder: an overview.

Susan L McElroy1, Paul E Keck.   

Abstract

Bipolar disorder (BD) is associated with obesity, overweight, and abdominal obesity, and BD individuals with obesity have a greater illness burden. Factors related to BD, its treatment, and the individual may all contribute to BD's association with obesity. Management strategies for the obese BD patient include use of medications with better metabolic profiles, lifestyle interventions, and adjunctive pharmacotherapy for weight loss. Obesity-related psychiatric and medical comorbidities should also be assessed and managed. Bariatric surgery may be an option for carefully selected patients. Greater research into the theoretical underpinnings and clinical management of the BD-obesity connection is needed.

Entities:  

Mesh:

Year:  2012        PMID: 22903246     DOI: 10.1007/s11920-012-0313-8

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


  97 in total

1.  Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level.

Authors:  Marc De Hert; Dan Cohen; Julio Bobes; Marcelo Cetkovich-Bakmas; Stefan Leucht; David M Ndetei; John W Newcomer; Richard Uwakwe; Itsuo Asai; Hans-Jurgen Möller; Shiv Gautam; Johan Detraux; Christoph U Correll
Journal:  World Psychiatry       Date:  2011-06       Impact factor: 49.548

Review 2.  The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders.

Authors:  Roger S McIntyre; Mohammad Alsuwaidan; Benjamin I Goldstein; Valerie H Taylor; Ayal Schaffer; Serge Beaulieu; David E Kemp
Journal:  Ann Clin Psychiatry       Date:  2012-02       Impact factor: 1.567

3.  Double-blind, placebo-controlled investigation of amantadine for weight loss in subjects who gained weight with olanzapine.

Authors:  Karen A Graham; Hongbin Gu; Jeffrey A Lieberman; Joyce B Harp; Diana O Perkins
Journal:  Am J Psychiatry       Date:  2005-09       Impact factor: 18.112

4.  A single-center, double-blind, placebo-controlled evaluation of lamotrigine in the treatment of obesity in adults.

Authors:  Charles H Merideth
Journal:  J Clin Psychiatry       Date:  2006-02       Impact factor: 4.384

5.  Mood disorders in laparoscopic sleeve gastrectomy patients: does it affect early weight loss?

Authors:  Debra A Semanscin-Doerr; Amy Windover; Kathleen Ashton; Leslie J Heinberg
Journal:  Surg Obes Relat Dis       Date:  2010-01-01       Impact factor: 4.734

Review 6.  Surgical treatment of morbid obesity among patients with bipolar disorder: a research agenda.

Authors:  Ameena T Ahmed; Thomas R W Blair; Roger S McIntyre
Journal:  Adv Ther       Date:  2011-04-04       Impact factor: 3.845

Review 7.  Weight gain in bipolar disorder: pharmacological treatment as a contributing factor.

Authors:  C Torrent; B Amann; J Sánchez-Moreno; F Colom; M Reinares; M Comes; A R Rosa; J Scott; E Vieta
Journal:  Acta Psychiatr Scand       Date:  2008-05-22       Impact factor: 6.392

8.  Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Authors:  Carlos A Zarate; Jennifer L Payne; Jaskaran Singh; Jorge A Quiroz; David A Luckenbaugh; Kirk D Denicoff; Dennis S Charney; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2004-07-01       Impact factor: 13.382

Review 9.  Are mood disorders and obesity related? A review for the mental health professional.

Authors:  Susan L McElroy; Renu Kotwal; Shishuka Malhotra; Erik B Nelson; Paul E Keck; Charles B Nemeroff
Journal:  J Clin Psychiatry       Date:  2004-05       Impact factor: 4.384

10.  Bromocriptine approved as the first medication to target dopamine activity to improve glycemic control in patients with type 2 diabetes.

Authors:  Michael A Via; Himani Chandra; Takako Araki; Matthew V Potenza; Maria Skamagas
Journal:  Diabetes Metab Syndr Obes       Date:  2010-03-26       Impact factor: 3.168

View more
  27 in total

1.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

2.  Bipolar disorder symptoms in patients seeking bariatric surgery.

Authors:  Karen B Grothe; Manpreet S Mundi; Susan M Himes; Michael G Sarr; Matthew M Clark; Jennifer R Geske; Sarah A Kalsy; Mark A Frye
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

Review 3.  What Happens to Patients with Bipolar Disorder after Bariatric Surgery? A Review.

Authors:  Saeedeh Majidi Zolbanin; Razieh Salehian; Ailar Nakhlband; Atefeh Ghanbari Jolfaei
Journal:  Obes Surg       Date:  2021-01-03       Impact factor: 4.129

Review 4.  The presentation, recognition and management of bipolar depression in primary care.

Authors:  Joseph M Cerimele; Lydia A Chwastiak; Ya-Fen Chan; David A Harrison; Jürgen Unützer
Journal:  J Gen Intern Med       Date:  2013-12       Impact factor: 5.128

5.  Shared Genetic Loci Between Body Mass Index and Major Psychiatric Disorders: A Genome-wide Association Study.

Authors:  Shahram Bahrami; Nils Eiel Steen; Alexey Shadrin; Kevin O'Connell; Oleksandr Frei; Francesco Bettella; Katrine V Wirgenes; Florian Krull; Chun C Fan; Anders M Dale; Olav B Smeland; Srdjan Djurovic; Ole A Andreassen
Journal:  JAMA Psychiatry       Date:  2020-05-01       Impact factor: 21.596

Review 6.  Insulin resistance takes center stage: a new paradigm in the progression of bipolar disorder.

Authors:  Cynthia V Calkin
Journal:  Ann Med       Date:  2019-08-27       Impact factor: 4.709

7.  Dietary influences on cognition.

Authors:  A C Reichelt; L E Stoeckel; L P Reagan; C A Winstanley; K A Page
Journal:  Physiol Behav       Date:  2018-03-01

8.  Clinical phenotype of bipolar disorder with comorbid binge eating disorder.

Authors:  Susan L McElroy; Scott Crow; Joanna M Biernacka; Stacey Winham; Jennifer Geske; Alfredo B Cuellar Barboza; Miguel L Prieto; Mohit Chauhan; Lisa R Seymour; Nicole Mori; Mark A Frye
Journal:  J Affect Disord       Date:  2013-06-03       Impact factor: 4.839

9.  Genome-wide association study of bipolar disorder accounting for effect of body mass index identifies a new risk allele in TCF7L2.

Authors:  S J Winham; A B Cuellar-Barboza; A Oliveros; S L McElroy; S Crow; C Colby; D-S Choi; M Chauhan; M Frye; J M Biernacka
Journal:  Mol Psychiatry       Date:  2013-12-10       Impact factor: 15.992

10.  Association of obesity and treated hypertension and diabetes with cognitive ability in bipolar disorder and schizophrenia.

Authors:  Colin A Depp; Martin Strassnig; Brent T Mausbach; Christopher R Bowie; Paula Wolyniec; Mary H Thornquist; James R Luke; John A McGrath; Ann E Pulver; Thomas L Patterson; Philip D Harvey
Journal:  Bipolar Disord       Date:  2014-04-12       Impact factor: 6.744

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.